Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriyuki Seta

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Modern Rheumatology|April 2, 2014
Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospective cohort study (KEIO-TCZ study) at week 52Keisuke Izumi, Yuko Kaneko, Hidekata Yasuoka, et al.
Arthritis Research & Therapy|November 6, 2010
Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosisYukie Yamaguchi, Yuka Okazaki, Noriyuki Seta, et al.
Internal Medicine (Tokyo, Japan)|July 17, 2015
Crohn's Disease in which the Patient Developed Aortitis during Treatment with AdalimumabHiroki Kiyohara, Tadakazu Hisamatsu, Katsuyoshi Matsuoka, et al.
International Journal of Molecular Sciences|November 8, 2018
Epidermal Fatty Acid-Binding Protein: A Novel Marker in the Diagnosis of Dry Eye Disease in Sjögren SyndromeMegumi Shinzawa, Murat Dogru, Seika Den, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Modern Rheumatology|April 2, 2014
Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospective cohort study (KEIO-TCZ study) at week 52Keisuke Izumi, Yuko Kaneko, Hidekata Yasuoka, et al.
Arthritis Research & Therapy|November 6, 2010
Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosisYukie Yamaguchi, Yuka Okazaki, Noriyuki Seta, et al.
Internal Medicine (Tokyo, Japan)|July 17, 2015
Crohn's Disease in which the Patient Developed Aortitis during Treatment with AdalimumabHiroki Kiyohara, Tadakazu Hisamatsu, Katsuyoshi Matsuoka, et al.
International Journal of Molecular Sciences|November 8, 2018
Epidermal Fatty Acid-Binding Protein: A Novel Marker in the Diagnosis of Dry Eye Disease in Sjögren SyndromeMegumi Shinzawa, Murat Dogru, Seika Den, et al.
Pageof 2